Bioequivalence and Bioavailability Forum

Dear Jansari!

❝ ❝ yes it's my Post..but still not getting any clearity about this...all PAR and guidance documents are available as per USFDA guidance..as Europe guidance is different for sevelamer carbonate..and they didn't accept USFDA guidance documents.. regulatory didn't accept our study which we were performed based on USFDA guidance ..so we have to perform the same study again as per Europe guidance ..so before starting the study i want to clear about the acceptance limit.

❝ ❝ they given the reference of following of guidance documents of Europe:: Guideline for locally applied , locally acting product in Gestrointestinal trac(CPMP/EWP/239/95Rev.1,Cor.1*) and this guidance documents given the acceptance limit as +- 10percentage..

Read the sentence again: In vitro similarity should be assessed with a ±10% acceptance range, unless otherwise justified.

Kindly refer Calcium acetate USFDA PSG.


Regards,
Divyen